🇺🇸 FDA
Patent

US 7642234

Beta-2-glycoprotein 1 is an inhibitor of angiogenesis

granted A61KA61K38/1709A61P

Quick answer

US patent 7642234 (Beta-2-glycoprotein 1 is an inhibitor of angiogenesis) held by The Board of Regents of the University of Texas System expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K38/1709, A61P, A61P17/00, A61P27/02